Advertisement

Familial Cancer

, Volume 8, Issue 1, pp 1–4 | Cite as

The 4154delA mutation carriers in the BRCA1 gene share a common ancestry

  • Silvija Ozolina
  • Olga Sinicka
  • Eriks Jankevics
  • Inna Inashkina
  • Jan Lubinski
  • Bohdan Gorski
  • Jacek Gronwald
  • Tatyana Nasedkina
  • Olga Fedorova
  • Ludmila Lyubchenko
  • Laima TihomirovaEmail author
Article

Abstract

Uncertainty exists whether the 4154delA mutation of the BRCA1 gene detected in unrelated individuals from Latvia, Poland and Russia is a founder mutation with a common ancestral origin. To trace back this problem we analysed the mutation-associated haplotype of the BRCA1 intragenic SNPs as well as intragenic and nearby STR markers in mutation carriers from the aforementioned populations. The mutation-associated SNP alleles were found to be “T-A-A-A-A-G” for six intragenic SNPs of the BRCA1 gene (IVS8-58delT, 3232A/G, 3667A/G, IVS16-68A/G, IVS16-92A/G, IVS18+66G/A, respectively). The alleles 195, 154, 210 and 181 were found to be associated with the 4154delA mutation for STR markers D17S1325, D17S855, D17S1328 and D17S1320, correspondingly. Further analysis of markers in the 4154delA mutation carriers from all three populations allows us to assert that all analysed mutation carriers share a common ancestry.

Keywords

BRCA1 Mutation Haplotype SNP STR Alleles 

Notes

Acknowledgments

The authors thank all patients who donated blood samples and filled in our questionnaires. We are grateful to Prof. E. Grens and Dr. J. Klovins for making available DNA samples and patients’ information from the Genome Database of the Latvian Population and Kristine Viksne for DNA isolation. This research was supported by the Collaborative project Nr. 05.23.04.1 funded by the Latvian Science Council. Entries in databases: BIC Database: http://research.nhgri.nih.gov/bic/. UniSTS Database: http://www.ncbi.nlm.nih.gov/sites/entrez?db=Unists.

References

  1. 1.
    Csokay B, Tihomirova L, Stengrevics A et al (1999) Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Mutation in brief no. 258 Online. Hum Mutat 14:92PubMedCrossRefGoogle Scholar
  2. 2.
    Gorski B, Byrski T, Huzarski T et al (2000) Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66:1963–1968PubMedCrossRefGoogle Scholar
  3. 3.
    Gayther SA, Harrington P, Russell P et al (1997) Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am J Hum Genet 60:1239–1242PubMedGoogle Scholar
  4. 4.
    Sokolenko AP, Mitiushkina NV, Buslov KG et al (2006) High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. Eur J Cancer 42:1380–1384PubMedCrossRefGoogle Scholar
  5. 5.
    Tikhomirova L, Sinicka O, Smite D et al (2005) High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia. Fam Cancer 4:77–84PubMedCrossRefGoogle Scholar
  6. 6.
    Gronwald J, Elsakov P, Gorski B, Lubinski J (2005) High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families. Breast Cancer Res Treat 94:111–113PubMedCrossRefGoogle Scholar
  7. 7.
    Ouchi T (2006) BRCA1 phosphorylation: biological consequences. Cancer Biol Ther 5:470–475PubMedCrossRefGoogle Scholar
  8. 8.
    Venkitaraman AR (2001) Functions of BRCA1 and BRCA2 in the biological response to DNA damage. J Cell Sci 114:3591–3598PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Silvija Ozolina
    • 1
  • Olga Sinicka
    • 1
  • Eriks Jankevics
    • 1
  • Inna Inashkina
    • 1
  • Jan Lubinski
    • 2
  • Bohdan Gorski
    • 2
  • Jacek Gronwald
    • 2
  • Tatyana Nasedkina
    • 3
  • Olga Fedorova
    • 3
  • Ludmila Lyubchenko
    • 4
  • Laima Tihomirova
    • 1
    Email author
  1. 1.Latvian Biomedical Research and Study CentreRigaLatvia
  2. 2.International Hereditary Cancer CenterPomeranian Medical UniversitySzczecinPoland
  3. 3.Engelhardt Institute of Molecular Biology, RASMoscowRussia
  4. 4.N. N. Blochin’s Russian Cancer Research Center RAMSMoscowRussia

Personalised recommendations